on the adhesion response of a model CTC cell line to curcumin treatment (Palange et al., 2012) .
The second group of papers focuses on the basic science of CTCs, and how we might expect them to behave while in the circulation. Geng et al. (2012) show that the breast cancer biomarker MUC1 can act as a simultaneous adhesion counter-receptor for both endothelial E-selectin and ICAM-1, and they present a new model for the metastatic adhesion cascade paradigm. Burdick et al. (2012) consider not only the adhesion characteristics of CTCs to E-selectin, but propose that surface ligand expression may signal phenotypic changes of cancer stem cells. Rejniak (2012) presents a computational model that can be used to simulate the shear-induced deformation of CTCs in the bloodstream. In a pair of related papers, Tormoen et al. (2012b) pose the question of whether CTCs play a role in coagulation and thrombosis in the bloodstream, and then Lee et al. (2012) describe their theoretical model of procoagulant CTCs under flow.
The third and final part of this special issue is focused on the characterization of patient CTCs, including new methods dedicated to this goal. Another contribution from Tormoen et al. (2012a) presents new coagulation factor probes for the identification of procoagulant CTCs. Diamond et al. (2012) describe their characterization of prostate cancer CTCs isolated from patient blood. Garcia-Villa et al. (2012) measured the γ-H2AX levels in CTCs obtained from patients undergoing chemotherapy. Finally, a pair of papers from McCarty and coworkers describes the application of precise image analysis methods to measure the density and volume of patient CTCs in ovarian (Phillips et al., 2012b) and breast cancer (Phillips et al., 2012a) , including a comparison with properties measured for normal blood cells.
The images featured on page 2 of this E-book, provided by Andrew Hughes of Cornell University, show viable CTCs isolated from a pancreatic cancer patient (upper image). The epithelial cancer cells stain positive for cytokeratin (red), and negative for the leukocyte marker CD45 (green), and show characteristically large nuclei stained in blue. The lower scanning electron micrograph shows a human leukocyte resting on a layer of halloysite nanotubes; these cells are unable to spread onto halloysite which enables efficient isolation of patient CTCs. This research is described in the lead paper by Greene et al. (2012) .
